Back to top

Image: Bigstock

Strength Seen in DexCom (DXCM): Stock Adds 5% in Session

Read MoreHide Full Article

DexCom, Inc. (DXCM - Free Report) was a big mover last session, as the company saw its shares rise over 5% on the day. The move came after Apple (AAPL) declared that it has collaborated with the company to deliver glucose monitoring on the latest Apple Watch operating system. This also led to far more shares changing hands than in a normal session. This reverses the recent trend of the company, as the stock is now down 3% in the past one-month time frame.

The company has seen one negative estimate revision in the last 30 days, while the Zacks Consensus Estimate remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Currently, DexCom carries a Zacks Rank #3 (Hold).

A better-ranked stock in the same industry is Inogen, Inc. (INGN - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is DXCM going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.                                                                                                                   
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


DexCom, Inc. (DXCM) - free report >>

Inogen, Inc (INGN) - free report >>

Published in